Xlife Sciences AG Plans Dual Listing on London Stock Exchange

Xlife Sciences AG (SIX:XLS) has announced a strategic decision to allow international co-investors to enter the stock and is planning a dual listing on the London Stock Exchange Group (LSEG). This move follows a thorough review by the Board of Directors and aims to increase market capitalization, stock price, liquidity, and tradability.

The company is collaborating with international co-investors and partners such as investment banks, funds, and market makers to execute the dual listing. This strategy is expected to enhance shareholder value in the short term and attract a broader international investor base, aligning market capitalization with valuation targets.

The necessary foundation for this initiative has been established through the Swiss Exchange's introduction of stock equivalence with the LSEG. Xlife Sciences AG appreciates the support and patience of its investors during this transition.